Literature DB >> 2922014

Renal insufficiency in treated essential hypertension.

S G Rostand1, G Brown, K A Kirk, E A Rutsky, H P Dustan.   

Abstract

We analyzed the clinical courses of 94 patients with treated primary hypertension and initially normal serum creatinine concentrations (less than or equal to 133 mumol per liter [less than or equal to 1.5 mg per deciliter]) who were followed for a mean (+/- SD) of 58 +/- 34 months (range, 12 to 174) to determine the frequency with which renal function deteriorated and the factors associated with deterioration. Fourteen patients (15 percent) had an increase in serum creatinine concentrations (greater than or equal to 35 mumol per liter [greater than or equal to 0.4 mg per deciliter]); in 16 percent of the 61 patients with apparently good control of blood pressure, the serum creatinine concentration rose 59 +/- 33 mumol per liter (0.67 +/- 0.38 mg per deciliter). Despite good control of diastolic blood pressure (less than or equal to 90 mm Hg), black patients were twice as likely as white patients to have elevations in serum creatinine (23 percent vs. 11 percent). Stepwise discriminant function analysis showed that a significant rise in the serum creatinine concentration was most likely to occur in association with older age, black race, a higher number of missed office visits, and employment as a laborer. We conclude that although renal function was preserved in 85 percent of patients with treated hypertension, it may deteriorate in some patients despite good blood-pressure control. Our observations may partly explain why hypertension, particularly among black persons, remains a leading cause of renal disease in the United States.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2922014     DOI: 10.1056/NEJM198903163201102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

1.  Racial differences in adherence to cardiac medications.

Authors:  Hyasmine Charles; Chester B Good; Barbara H Hanusa; Chung-Chou H Chang; Jeff Whittle
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

2.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

Review 3.  Interventions in chronic renal failure.

Authors:  J R Curtis
Journal:  BMJ       Date:  1990-09-29

4.  African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Authors:  Gregory E Malat; Christine Culkin; Aniruddha Palya; Karthik Ranganna; Mysore S Anil Kumar
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

5.  Adverse effects of captopril in hospital outpatients with hypertension.

Authors:  T Walley; P Winstanley; D Roberts; M Grimmer; M Orme; A Breckenridge
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

6.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

Review 7.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

Review 8.  Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status.

Authors:  A L Kamper
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 9.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Authors:  R I Ogilvie; E D Burgess; J R Cusson; R D Feldman; L A Leiter; M G Myers
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

Review 10.  Cardiovascular disease in patients with chronic kidney disease.

Authors:  Julian Wright; Alastair Hutchison
Journal:  Vasc Health Risk Manag       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.